Revolution Medicines to Acquire EQRx in All-Stock Deal

Change Healthcare Acquires eRx Network

May 4, 2020

Healthcare Services

Change Healthcare has exercised its option and acquired 100% of eRx Network for $212.9 million plus cash, with eRx generating approximately $67 million of revenue for the twelve months ended February 29, 2020. The acquisition expands Change Healthcare's pharmacy-focused technology and data capabilities, enabling tighter integration of pharmacy interactions with claims, billing and payment data to drive improved outcomes and new product opportunities.

CoachCare Acquires MD Revolution

June 23, 2025

Healthcare Services

CoachCare has acquired MD Revolution to create an expanded national remote care platform that combines CoachCare’s device infrastructure and services with MD Revolution’s EHR-integrated care management software. The combined company will operate as “MD Revolution: A CoachCare Company,” serve more than 250 healthcare organizations, and support over half a million patients while broadening remote monitoring, chronic care management, and population health capabilities.

Equillium Acquires Metacrine in All-Stock Transaction

September 6, 2022

Biotechnology

Equillium, Inc. will acquire Metacrine Inc. in an all-stock merger intended to strengthen Equillium's cash position by adding an estimated $33 million at closing and extending its cash runway into 2024. The deal adds Metacrine's FXR platform, including lead candidate MET642, to Equillium's pipeline while Metacrine CEO Preston Klassen will join Equillium's board; closing is subject to shareholder approvals and customary conditions.

OptimizeRx Acquires RMDY Health

September 5, 2019

Cloud & SaaS

OptimizeRx Corporation (NASDAQ: OPRX) agreed to acquire RMDY Health, a digital therapeutics SaaS platform, for $16 million in cash and equity ($8M cash, $8M equity). The deal expands OptimizeRx's patient engagement capabilities into digital therapeutics and adds new client segments including payers, MedTech and medical associations; RMDY will retain its technology team in Tel Aviv while U.S. personnel will operate from OptimizeRx's U.S. offices.

OptimizeRx Acquires EvinceMed Specialty Drug Market Access Platform

March 15, 2022

Healthcare Services

OptimizeRx Corporation acquired the EvinceMed platform and related assets to integrate end-to-end automation for specialty pharmaceutical transactions into its point-of-care network. The purchase expands OptimizeRx’s capabilities for specialty drug prescribing, patient enrollment into manufacturer support programs, and point-of-dispense connectivity to improve patient access and accelerate time-to-therapy.

22nd Century Group Acquires RX Pharmatech Ltd

January 24, 2023

Food & Beverage

22nd Century Group, through its GVB Biopharma business, acquired UK-based RX Pharmatech Ltd, a distributor of cannabinoid/CBD products and holder of numerous U.K. novel food applications. The deal includes $650,000 up-front in cash and stock plus a three-year equity earn-out tied to revenue milestones and aims to strengthen 22nd Century's access and distribution in the U.K. and EU consumer CBD market.